Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2007-03-20
2010-11-16
Mertz, Prema (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S402000, C435S069520, C435S069700
Reexamination Certificate
active
07834152
ABSTRACT:
Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
REFERENCES:
patent: 5011684 (1991-04-01), Strom
patent: 5116964 (1992-05-01), Capon
patent: 5262522 (1993-11-01), Gearing
patent: 5552303 (1996-09-01), Grabstein
patent: 5574138 (1996-11-01), Grabstein
patent: 5707616 (1998-01-01), Grabstein
patent: 5747024 (1998-05-01), Grabstein
patent: 5892001 (1999-04-01), Grabstein
patent: 6001973 (1999-12-01), Strom et al.
patent: 2210491 (1996-08-01), None
patent: WO 88/07089 (1988-09-01), None
patent: WO 95/27722 (1995-10-01), None
patent: WO 96/04306 (1996-02-01), None
patent: WO 96/26274 (1996-08-01), None
Mikayama et al. Proc. Natl. Acad. Sci. USA vol. 90, pp. 10056-10060.
Voet et al. Biochemistry John Wiley & Sons, Inc., pp. 126-128 and 228-234.
Ajjan et al., “Detection of IL-12, IL-13, and IL-15 Messenger Ribonucleic Acid in the Thyroid of Patients with Autoimmune Thyroid Disease”,J. Clin. Endocrinol. Metab., 82(2):666-669, 1997.
Akatsuka et al., “Synovial Mononuclear Cells Consist with T Cells Which Produce High Levels of Tumor Necrosis Factor α”,Microbiol. Immunol., vol. 41, (1997) pp. 367-370.
Ameglio et al., “Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients withPemphigus vulgarisrelationships with peripheral blood neutrophil counts, disease severity and duration and patients' age”,J. Biol. Regul. Homest. Agents, 13(4):220-224, 1999.
Anderson et al., Functional Characterization of the Human Interleukin-15 Receptor α Chain and Close Linkage of IL15RA and IL2RA Genes,J. Bio. Chem. 270:29862-29869 (1995).
Aringer et al., “Serum interleukin-15 is elevated in systemic lupus erythematosus”,Rheumatology(Oxford) 40(8):8760881, 2001.
Armitage et al., “IL-15 Has Stimulatory Activity for the Induction of B Cell Proliferation and Differentiation”,J. Immunology, vol. 154 (1995) pp. 483-490.
Baan et al., “Increased intragraft IL-15 mRNA expression after liver transplantation”,Clin. Transplant. 12(3):212-218, 1998.
Baan et al., “The Macrophage-Derived T-Cell Growth Factor Interleukin-15 Is Present in Interleukin-2-Independent Rejection After Clinical Heart and Liver Transplantation”,Transplant Proc. 31(7):2726-2728, 1999.
Baan et al., “Anti-CD25 Therapy Reveals the Redundancy of the Intragraft Cytokine Network After Clinical Heart Transplantation”,Transplantation67(6):870-876, 1999.
Bamford et al., The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells,Proc. Nat. Acad. Sciences, 91:4940-4944 (1994).
Blanar et al., “Interaction Cloning: Identification of a Helix-Loop-Helix Zipper Protein That Interacts with c-Fos”,Science, 256:1014-1018 (1992).
Brekke et al., “Structure-Function Relationships of Human IgG”,The Immunologist, vol. 2 (1994) pp. 125-130.
Burger et al., “Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated t lymphocytes”,Arthritis & Rheumatism, vol. 41 (1998).
Burton et al., “A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells”,Proc. Nat. Acad. Sciences, 91:4935-4939 (1994).
Carson et al., “Interleukin (IL) 15 Is a Novel Cytokine That Activates Human Natural Killer Cells via Components of the IL-2 Receptor”,J. Exper. Medicine180:1395-1403 (1994).
Carson, “Unconventional T-cell activation by IL-15 in rheumatoid arthritis”,Nature Med. 3(2):148-149, 1997.
Chae et al., “Mutant IL-15 Protein Exerting Antagonistic Effects on IL-15 Triggered Cell Proliferation”,J. American Society of Nephrology7:1654 (1996).
Chae et al., “Distribution of IL-15 Receptor α-Chains on Human Peripheral Blood Mononuclear Cells and Effect of Immunosuppressive Drugs on Receptor Expression”,The Journal of Immunology, 157: 2813-2819 (1996).
Courtenay et al., “Immunisation against heterologous type II collagen induces arthritis in mice”,Nature283:5748 (1980).
Cunningham et al., “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis”,Science, 244, 1081-1085 (1989).
Elliott et al., “Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.”,Lancet, 344:8930:1105-10 (1994).
Elliott et al., “Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.”,Lancet344:8930:1125-27 (1994).
George et al., “Current methods in sequence comparison and analysis”,Macromolecular Sequencing and Synthesis Selected methods and Applications, pp. 127-149 (1988).
Giri et al., “IL-15, A Novel T Cell Growth Factor That Shares Activities and Receptor Components with IL-2”,J. Leukocyte Biology, 57:763-766 (1995).
Giri et al., “Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor”,EMBO Journal14:3654-3663 (1995).
Giri et al., Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15,EMBO Journal13:2822-2830 (1994).
Grabstein et al., “Cloning of a T Cell Growth Factor That Interacts with the β Chain of the Interleukin-2 Receptor”,Science, 264:965-968 (1994).
Hatakeyama et al., “A Restricted Cytoplasmic Region of IL-2 Receptor β Chain Is Essential for Growth Signal Transduction but Not for Ligand Binding and Internalization”,Cell, 59:837-845 (1989).
Isler et al., “Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69”,Eur. Cytokine Netw., 4:1 15-23, (1993).
Kim et al., Targeting the I1-15 Receptor with an Antagonist IL-15 Mutant/Fcγ2a Protein Blocks Delayed-type HypersensitivityJournal of Immunology160:5742-5748 (1998).
Kirman and Nielsen, “Increased Number of Interleukin-15-Expressing Cells in Active Ulcerative Colitis”,Am. J. Gastroenterol., 91(9):1789-1794, 1996.
Kirman et al., “Interleukin-15 and its role in chronic inflammatory diseases”,Inflamm. Res., 47(7):285-289, 1998.
Kivisakk et al., “IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS)”,Clin. Exp. Immunol. 111(1):193-197, 1998.
Knight et al., “Construction and initial characterization of a mouse-human chimeric anti-TNF antibody”Molecular Immunology30:16, 1443-1453 (1993).
LeClair et al., “The p50 subunit of NF-κB associates with the NF-IL6 transcription factor”,Proc. Nat. Acad. Sciences, 89:8145-8149 (1992).
Li et al., “Differential Expression Of T-cell Growth Factors in Rejecting Murine Islet and Human Renal Allografts”,Transplantation, 66(2):265-268, 1998.
Lin et al., “The Role of Shared Receptor Motifs and Common Stat Proteins in the Generation of Cytokine Pleiotropy and Redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15”,Immunity, 2:331-339 (1995).
Liu et al., “IL-15 Is Highly Expressed in Inflammatory Bowel Disease and Regulates Local T Cell-Dependent Cytokine Production”,J. Immunol. 164(7):3608-3615, 2000.
Maslinski et al., “Interleukin-2 (IL-2) Induces Tyrosine Kinase-dependent Translocation of Active Raf-1 from the IL-2 Receptor into the Cytosol”.J. Biological Chemistry267:15281-15284 (1992).
Maslinski et al., “
Maslinski Wlodzimierz
Strom Terry B.
Beth Israel Deaconess Medical Center Inc.
Fish & Richardson P.C.
Mertz Prema
LandOfFree
Antagonists of interleukin-15 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of interleukin-15, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of interleukin-15 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233502